X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 11c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.72), $0.11 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
• Compass Point Reiterates Buy Rating on WhiteFiber Inc (WYFI)
• Global Water Resources (GWRS) Tops Q2 EPS by 1c